A novel series of indazole-/indole-based glucagon receptor antagonists

被引:12
|
作者
Lin, Songnian [1 ]
Zhang, Fengqi [1 ]
Jiang, Guoqiang [1 ]
Qureshi, Sajjad A. [1 ]
Yang, Xiaodong [1 ]
Chicchi, Gary G. [1 ]
Tota, Laurie [1 ]
Bansal, Alka [1 ]
Brady, Edward [1 ]
Trujillo, Maria [1 ]
Salituro, Gino [1 ]
Miller, Corey [1 ]
Tata, James R. [1 ]
Zhang, Bei B. [1 ]
Parmee, Emma R. [1 ]
机构
[1] Merck Res Labs, Early Dev & Discovery Sci & Preclin Dev, Kenilworth, NJ 07033 USA
关键词
Glucagon receptor antagonist; Indazole; Indole; Diabetes; Glucose lowering; HEPATIC GLUCOSE-PRODUCTION; THERAPEUTIC TARGET;
D O I
10.1016/j.bmcl.2015.08.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel, potent series of glucagon receptor antagonists (GRAs) was discovered. These indazole-and indole-based compounds were designed on an earlier pyrazole-based GRA lead MK-0893. Structure-activity relationship (SAR) studies were focused on the C3 and C6 positions of the indazole core, as well as the benzylic position on the N-1 of indazole. Multiple potent GRAs were identified with excellent in vitro profiles and good pharmacokinetics in rat. Among them, GRA 16d was found to be orally active in blunting glucagon induced glucose excursion in an acute glucagon challenge model in glucagon receptor humanized (hGCGR) mice at 1, 3 and 10 mg/kg (mpk), and significantly lowered acute glucose levels in hGCGR ob/ob mice at 3 mpk dose. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4143 / 4147
页数:5
相关论文
共 50 条
  • [31] Discovery of novel indole-based aroylhydrazones as anticonvulsants: Pharmacophore-based design
    Angelova, Violina T.
    Rangelov, Miroslav
    Todorova, Nadezhda
    Dangalov, Miroslav
    Andreeva-Gateva, Pavlina
    Kondeva-Burdina, Magdalena
    Karabeliov, Valentin
    Shivachev, Boris
    Tchekalarova, Jana
    BIOORGANIC CHEMISTRY, 2019, 90
  • [32] Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands
    Yarim, Mine
    Koksal, Meric
    Schepmann, Dirk
    Wuensch, Bernard
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (05) : 869 - 875
  • [33] Design, synthesis, and effects of novel phenylpyrimidines as glucagon receptor antagonists
    Choi, Hojung
    Lee, Chang-Yong
    Park, Eun-Young
    Lee, Kyoung Mee
    Shin, Dongyun
    Jun, Hee-Sook
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (21) : 5701 - 5710
  • [34] Human glucagon receptor antagonists based on alkylidene hydrazides
    Ling, A
    Plewe, M
    Gonzalez, J
    Madsen, P
    Sams, CK
    Lau, J
    Gregor, V
    Murphy, D
    Teston, K
    Kuki, A
    Shi, S
    Truesdale, L
    Kiel, D
    May, J
    Lakis, J
    Anderes, K
    Iatsimirskaia, E
    Sidelmann, UG
    Knudsen, LB
    Brand, CL
    Polinsky, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 663 - 666
  • [35] Discovery of selective indole-based prostaglandin D2 receptor antagonist
    Iwahashi, Maki
    Shimabukuro, Atsushi
    Onoda, Takahiro
    Matsunaga, Yoko
    Okada, Yutaka
    Matsumoto, Ryoji
    Nambu, Fumio
    Nakai, Hisao
    Toda, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4574 - 4588
  • [36] The design and synthesis of a novel series of indole derived selective ETA antagonists
    Rawson, DJ
    Dack, KN
    Dickinson, RP
    James, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (02) : 125 - 128
  • [37] Novel indole-based inhibitors of IMPDH: Introduction of hydrogen bond acceptors at indole C-3
    Watterson, SH
    Dhar, TGM
    Ballentine, SK
    Shen, ZQ
    Barrish, JC
    Cheney, D
    Fleener, CA
    Rouleau, KA
    Townsend, R
    Hollenbaugh, DL
    Iwanowicz, EJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (07) : 1273 - 1276
  • [38] Novel Indole-Based Analogs of Melatonin: Synthesis and in Vitro Antioxidant Activity Studies
    Shirinzadeh, Hanif
    Eren, Burcu
    Gurer-Orhan, Hande
    Suzen, Sibel
    Ozden, Seckin
    MOLECULES, 2010, 15 (04) : 2187 - 2202
  • [39] Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones
    Cihan-Ustundag, Gokce
    Gursoy, Elif
    Naesens, Lieve
    Ulusoy-Guzeldemirci, Nuray
    Capan, Gultaze
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (02) : 240 - 246
  • [40] Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)
    Lu, Jianyu
    Chan, Chi-chung
    Sun, Deheng
    Hui, Guoping
    He, Huijun
    Li, Jian
    Dong, Jiaqiang
    Liu, Kai
    Shen, Liang
    Hu, Lihong
    Gu, Qingyang
    Chen, Shuhui
    Wang, Tielin
    Gong, Ting
    Tang, Wei
    Li, Xiaoting
    Zhu, Xiaotong
    Zeng, Xu
    Zhu, Yingjie
    Xia, Yuanfeng
    Huang, Yuanyuan
    Zhu, Yusong
    Liu, Zhenteng
    Ding, Charles Z.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 66